Charles Ballantyne
Finanzdirektor/CFO bei HANSA BIOPHARMA AB
Vermögen: - $ am 30.04.2024
Profil
Charles Evan Ballantyne currently works at PreveCeutical Medical, Inc., as Independent Director from 2023, Trovis Pharmaceuticals LLC, as Chief Financial Officer & Senior Vice President from 2006, and Hansa Biopharma AB, as Chief Financial Officer from 2024.
Mr. Ballantyne also formerly worked at Clinical Data, Inc., as Chief Financial Officer & Executive Vice President from 2010 to 2011, ACNielsen Corp., as Chief Operating Officer & Vice President, Agenus, Inc., as Chief Financial Officer from 2015 to 2016, Avedro, Inc., as Chief Financial Officer, Knowledge Impact, Inc., as Chief Financial Officer in 2002, Avalon Pharmaceuticals, Inc., as Chief Financial Officer & Senior Vice President from 2009 to 2012, Theriva Biologics, Inc., as Chief Financial Officer, Secretary & Treasurer from 2012 to 2015, Orchestra BioMed, Inc., as Chief Financial Officer, Oncxerna Therapeutics, Inc., as Chief Financial Officer from 2021 to 2023, and Gain Therapeutics, Inc., as Chief Financial Officer & Secretary from 2023 to 2024.
Mr. Ballantyne received his undergraduate degree from the University of Western Ontario and Masters Business Admin degree from the University of Windsor.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
GAIN THERAPEUTICS, INC.
-.--% | 10.04.2023 | 0 ( -.--% ) | - $ | 30.04.2024 |
Aktive Positionen von Charles Ballantyne
Unternehmen | Position | Beginn |
---|---|---|
PREVECEUTICAL MEDICAL INC. | Direktor/Vorstandsmitglied | 17.02.2023 |
HANSA BIOPHARMA AB | Finanzdirektor/CFO | 01.03.2024 |
Trovis Pharmaceuticals LLC | Finanzdirektor/CFO | 01.08.2006 |
Ehemalige bekannte Positionen von Charles Ballantyne
Unternehmen | Position | Ende |
---|---|---|
GAIN THERAPEUTICS, INC. | Finanzdirektor/CFO | 01.03.2024 |
Oncxerna Therapeutics, Inc.
Oncxerna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Oncxerna Therapeutics, Inc. develops oncology drugs. The firm uses RNA-based biomarker platform. It focuses on clinical-stage therapies. The company was founded by Laura E. Benjamin in 2018 and is headquartered in Boston, MA. | Finanzdirektor/CFO | 01.01.2023 |
AGENUS INC. | Finanzdirektor/CFO | 29.07.2016 |
THERIVA BIOLOGICS, INC. | Finanzdirektor/CFO | 14.05.2015 |
Clinical Data, Inc.
Clinical Data, Inc. Medical SpecialtiesHealth Technology Clinical Data, Inc. manufactured and distributed scientific instruments used in clinical and analytical laboratories. The company was founded in 1972 and was headquartered in Newton, MA. | Finanzdirektor/CFO | 01.04.2011 |
Ausbildung von Charles Ballantyne
University of Western Ontario | Undergraduate Degree |
University of Windsor | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 5 |
---|---|
AGENUS INC. | Health Technology |
THERIVA BIOLOGICS, INC. | Health Technology |
HANSA BIOPHARMA AB | Health Technology |
PREVECEUTICAL MEDICAL INC. | Health Technology |
GAIN THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 8 |
---|---|
Clinical Data, Inc.
Clinical Data, Inc. Medical SpecialtiesHealth Technology Clinical Data, Inc. manufactured and distributed scientific instruments used in clinical and analytical laboratories. The company was founded in 1972 and was headquartered in Newton, MA. | Health Technology |
ACNielsen Corp.
ACNielsen Corp. Miscellaneous Commercial ServicesCommercial Services ACNielsen Corp. provides market research, information and analysis services. The company was founded by Arthur C. Nielsen in 1923 and is headquartered in New York, NY. | Commercial Services |
Avedro, Inc.
Avedro, Inc. Medical SpecialtiesHealth Technology Avedro, Inc. develops ophthalmic medical devices and pharmaceutical products. The firm’s products include KXL System, Mosaic system, IROC system and Riboflavin family. Its procedure includes Lasic Xtra, accelerated cross-linking and photorefractive intrastromal cross-linking. The company was founded by David F. Muller and B. Stuart Trembly on November 6, 2002 and is headquartered in Waltham, MA. | Health Technology |
Knowledge Impact, Inc.
Knowledge Impact, Inc. Packaged SoftwareTechnology Services Knowledge Impact, Inc. provides application software services. It offers e-learning and performance support solutions for enterprise applications such as CRM and ERP. The firm provides KnowledgeMate, an e-learning solution, as well as web-based and computer-based training. Knowledge Impact was founded in 1985 and is headquartered in Wayland, MA. | Technology Services |
Avalon Pharmaceuticals, Inc.
Avalon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Avalon Pharmaceuticals, Inc. was a biopharmaceutical company focused on the discovery, development and commercialization of cancer therapeutics. The company was founded in November 1999 and headquartered in Germantown, MD. | Health Technology |
Trovis Pharmaceuticals LLC | |
Orchestra BioMed, Inc.
Orchestra BioMed, Inc. Medical SpecialtiesHealth Technology Orchestra BioMed, Inc. develops therapies for cardiovascular diseases. The firm offers BackBeat CNT and Virtue SEB. The company was founded in 2017 and is headquartered in New Hope, PA. | Health Technology |
Oncxerna Therapeutics, Inc.
Oncxerna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Oncxerna Therapeutics, Inc. develops oncology drugs. The firm uses RNA-based biomarker platform. It focuses on clinical-stage therapies. The company was founded by Laura E. Benjamin in 2018 and is headquartered in Boston, MA. | Health Technology |